However, in patients with cirrhosis, this protective effect did not reach statistical significance (adjusted HR 0.96, 95% CI 0.84–1.09).
← all excerpts
A review of MASLD-related hepatocellular carcinoma: progress in pathogenesis, early detection, and therapeutic interventions.
1
—
—